Market closed
Kodiak Sciences/KOD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Kodiak Sciences
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.
Ticker
KOD
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
111
Website
Kodiak Sciences Metrics
BasicAdvanced
$180M
Market cap
-
P/E ratio
-$3.77
EPS
2.37
Beta
-
Dividend rate
Price and volume
Market cap
$180M
Beta
2.37
52-week high
$7.77
52-week low
$1.37
Average daily volume
209K
Financial strength
Current ratio
10.594
Quick ratio
10.339
Long term debt to equity
30.707
Total debt to equity
35.317
Interest coverage (TTM)
-42,382.40%
Management effectiveness
Return on assets (TTM)
-26.72%
Return on equity (TTM)
-71.50%
Valuation
Price to book
0.84
Price to tangible book (TTM)
0.84
Price to free cash flow (TTM)
-1.133
Growth
Earnings per share change (TTM)
-33.98%
3-year earnings per share growth (CAGR)
-0.74%
What the Analysts think about Kodiak Sciences
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Kodiak Sciences stock.
Kodiak Sciences Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Kodiak Sciences Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Kodiak Sciences stock?
Kodiak Sciences (KOD) has a market cap of $180M as of October 26, 2024.
What is the P/E ratio for Kodiak Sciences stock?
The price to earnings (P/E) ratio for Kodiak Sciences (KOD) stock is 0 as of October 26, 2024.
Does Kodiak Sciences stock pay dividends?
No, Kodiak Sciences (KOD) stock does not pay dividends to its shareholders as of October 26, 2024.
When is the next Kodiak Sciences dividend payment date?
Kodiak Sciences (KOD) stock does not pay dividends to its shareholders.
What is the beta indicator for Kodiak Sciences?
Kodiak Sciences (KOD) has a beta rating of 2.37. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.